Lv41
520 积分 2024-09-06 加入
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma The FUMANBA-1 Nonrandomized Clinical Trial
6天前
已完结
Emerging Biomarkers for Monitoring Chimeric Antigen Receptor T-Cell Therapy
9天前
已完结
Ways to fit a PK model with some data below the quantification limit
15天前
已完结
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy
1个月前
已完结
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling
2个月前
已完结
Dendritic cells: a link between innate and adaptive immunity
2个月前
已完结
皖公网安备34019202002308
